NHS Surrey Commissions Risk Stratification Tool from Docobo Ltd to Reduce Unplanned Admissions

Innovative technology developed by UK company Docobo Ltd, will support NHS Surrey in their initiatives to manage patients at home and reduce hospital admissions. NHS Surrey has commissioned Docobo Ltd to supply its new risk stratification tool, ArtemusICS™, that will enable GP practices in Surrey to better target their resources to deliver better outcomes for the 1.2 million people living in Surrey.

The tool takes patient data from both Primary and Secondary care and, through detailed analysis, will identify patients at risk of requiring future healthcare resources and who would likely benefit from a specific Long Term Condition intervention. The data is presented in a convenient 'dashboard' format so that information can be easily accessed via secure web access by authorised staff at GP practices. Data can be examined based on groups of patients, such as by practice or locality, or by clinical condition. Each patient is allocated a 'risk score' which predicts their risk of a hospital admission in the next year. Their GP can view this data and use it to direct their resources more effectively. This enables them toprovide more targeted personalised care and will help to identify and treat health problems earlier. Furthermore, the patients' risk scores can be monitored regularly to examine the effect effectiveness of treatments and interventions.

"We chose the ArtemusICS tool because it enables clinicians to target patients who would benefit from greater intervention, helping to reduce unplanned hospital admissions, which can be very distressing. Using this tool helps clinicians achieve the best possible outcomes for their patients and it also enables them to allocate their resources to best effect," said Christine Ratcliffe, Associate Director of IT Programmes, NHS Surrey. "The tool creates dashboards, which are easy to access, and give clinicians valuable insight into primary and seconday care data, helping them identify those most at risk and enabling them to tailor care to meet their needs. Docobo have worked with us to develop the tool to meet our requirements, and have delivered a quality product that is already making a real difference to GPs."

"Docobo is proud that our ArtemusICS system has been selected by NHS Surrey," said Adrian Flowerday, Managing Director, Docobo Ltd. "We are particularly delighted to have had the opportunity to work closely with Surrey to develop this tool to precisely fit their needs and we look forward to working with the GP practices in Surrey to roll this out."

About Docobo Ltd
Docobo Ltd is a UK medical device company that supplies eHealth solutions to enable Community Care and improve the quality of life of patients, carers and clinicians. More than 40 PCTs and Trusts in the UK and several international healthcare organisations are currently using doc@HOME Telehealth to support their patients.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...